The results of this study demonstrate that GR/let-7f-5p/TGFBR1 may be important in GC-inhibited osteoblast differentiation and that let-7f-5p ameliorates GC-induced bone loss, indicating that let-7f-5p would be a potential therapeutic target for GIOP. Here, TGFBR1 is linked to gastric cancer.